Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is inclined "down here at $17," regarding Hewlett...
The stock has shed over half its value in the past year, leading to heightened scrutiny and investor apprehension.
B. Riley Securities analyst Jeff Van Sinderen maintains Herbalife (NYSE:HLF) with a Buy and raises the price target from $16...
DA Davidson analyst Linda Bolton Weiser maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $9.5 ...
Full-year 2024 guidance revised: net sales reduced, adjusted EBITDA raised, capital expenditures reaffirmed.
Herbalife (NYSE:HLF) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.39 by 38.46...
Study shows no link between daily multivitamin use and lower risk of death in healthy adults. No difference in mortality from c...
